Position in SLNO
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$1,480,853
+$1,480,853 QoQ
Shares Held
44,231
Ownership
0.085%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#106
of 224 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in SLNO
reported options exposure · as of Sep 30, 2025CallValue
$8,788,000
CallShares
130,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Anson Funds Management LP holds $3,211,607 across 3 Biotechnology names. SLNO ranks #1 (46.1% of the industry book) .
All Filings in SLNO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,480,853 | 44,231 | Shares | Defined | 2026-05-19 | |
| 2025-09-30 | $8,788,000 | 130,000 | Call | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||